Whether you are a potential SAB member, pharmaceutical partner, clinical collaborator, Shariah-compliant investor or simply passionate about memory health - we want to hear from you.
We are recruiting 5 world-class neuroscientists, EEG specialists and neuroethicists for our SAB. Offer: co-authorship on first clinical publications. No financial compensation - scientific legacy is the incentive.
NIMHANS, AIIMS and CMC Vellore are our target sites for ZAKR-SNR-001 and ZAKR-AD-001. We provide: device, protocol, statistical plan and publication rights. You provide: IRB, clinical infrastructure and patient cohort.
ZAKR-AD-001 (100-patient RCT, 12 months) is designed and costed. We seek a pharmaceutical Musharakah partner to co-fund the RCT. Revenue and publication rights shared proportionally. Approaches Eisai and Roche.
We seek seed funding via Mudarabah profit-sharing. No riba. No guaranteed return. INR 2–3 Crore target for Month 1–18. All agreements certified by Dar Al-Ifta scholar.